C. Vogelmeier, F. Maltais, E. Kerwin, L. Bjermer, I. Naya, L. Tombs, I. Boucot, M. Watkins, David A. Lipson, C. Compton, P. Jones
{"title":"在无吸入皮质类固醇的慢性阻塞性肺疾病患者中,乌莫替尼/维兰特罗与支气管扩张剂单药治疗预防临床重要恶化:EMAX试验的前瞻性分析","authors":"C. Vogelmeier, F. Maltais, E. Kerwin, L. Bjermer, I. Naya, L. Tombs, I. Boucot, M. Watkins, David A. Lipson, C. Compton, P. Jones","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preventing Clinically Important Deterioration with Umeclidinium/Vilanterol Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: A Prospective Analysis of the EMAX Trial\",\"authors\":\"C. Vogelmeier, F. Maltais, E. Kerwin, L. Bjermer, I. Naya, L. Tombs, I. Boucot, M. Watkins, David A. Lipson, C. Compton, P. Jones\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":311626,\"journal\":{\"name\":\"B45. COPD: TREATMENT\",\"volume\":\"21 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B45. COPD: TREATMENT\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B45. COPD: TREATMENT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preventing Clinically Important Deterioration with Umeclidinium/Vilanterol Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: A Prospective Analysis of the EMAX Trial